Non-Interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NIELS)
Phase of Trial: Phase IV
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Vismodegib (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- Sponsors Roche
- 01 Jun 2016 Planned End Date changed from 1 Jun 2019 to 1 Mar 2019.
- 01 Jun 2016 Planned primary completion date changed from 1 Jun 2019 to 1 Mar 2019.
- 17 Feb 2016 New trial record